Abstract
Ananworanich J, Nuesch R, Le Braz M, et al. AIDS. 2003;17:F33–F37 Although highly active antiretroviral therapy (HAART) has dramatically improved the duration and quality of life of human immunodeficiency virus (HIV)-infected individuals, an increasing number of serious complications are being identified among patients who are treated with these agents for long periods of time. Strategies that reduce the total drug exposure among infected patients while maintaining the stability of HIV and T cell levels would be welcomed. Scheduled or structured …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
